ALCAlcon Inc.

$72.70

$62.0252 weeks$89.68

Price

$72.70-15%1Y

1M+8.2%1Y-15%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Average

6/10

Value44

Quality81

Momentum38

Growth55

Strongest Quality, weakest Momentum · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

Alcon is the global leader in eye care with $10.3 billion in net sales during the year ended December 31, 2025. We research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. Based on sales for the year ended December 31, 2025, we are the number one company by global market share in the ophthalmic surgical market and in the vision care market.

In the company’s own words · 20-F filed Feb 24, 2026 · SEC EDGAR

P/E (TTM)54.7

Market Cap$31.54B

1Y Return-15%

5Y Return+0.30%

Alcon Inc. (ALC) reported revenue of $5.33B in H2 2025 (quarter ended December 31, 2025), up 14% from the same quarter a year earlier. That came with a gross margin of 56% and net income of $454M (8.5% of revenue). For the full year FY2025, revenue was $10.4B (+4.9% year on year) and net income $980M.

Raw charts

7 series · TTM

As reported to the SEC, without any scoring.

Medical Instruments & Supplies

Ranks #18 of 27 by Smart Score

West Pharmaceutical Services